At Tuesday’s spring board meeting, OMRF recognized 11 board members for their years of service and honored four scientists for scientific achievement.
The American Association of Immunologists has named OMRF’s Paul Kincade to its 2019 class of Distinguished Fellows.
Glioblastoma is an aggressive form of brain cancer with no cure, but a new OMRF discovery offers hope.
OMRF’s Courtney Griffin succeeds OCASCR’s founding scientific director, Paul Kincade, who is retiring.
Two grants will enable OMRF scientists to examine genes thought to play a role in lupus.
The grants will support more than 50 research and clinical projects, purchase scientific equipment and fund recruitment.